Chemistry: molecular biology and microbiology – Vector – per se
Reexamination Certificate
2000-08-08
2003-07-22
Housel, James (Department: 1648)
Chemistry: molecular biology and microbiology
Vector, per se
C424S093200, C424S093600, C435S069100, C435S325000, C435S455000, C435S456000, C435S457000, C536S023100, C536S023720, C536S024300
Reexamination Certificate
active
06596535
ABSTRACT:
STATEMENT OF RIGHTS TO INVENTIONS MADE UNDER FEDERALLY SPONSORED RESEARCH
Not applicable.
TECHNICAL FIELD
The invention is in the field of viral constructs for gene delivery, in particular recombinant viral vectors, such as adeno-associated virus (AAV) vectors, for use in gene therapy and genomics screening.
BACKGROUND
Recombinant vectors based on parvovirus, such as adeno-associated virus (AAV), show promise for gene therapy. However, obtaining efficient, sufficient levels of expression of a transgene in various cell types has presented problems. Some cell types are impermissive in the sense that initiation of transcription or translation of the transgene is inefficient, with expression accordingly very slow to initiate, if it initiates at all. Yet in many contexts it is desirable to achieve sufficiently rapid expression.
Parvoviruses are small, encapisdated, single-stranded DNA viruses, the DNA genome of which is flanked by inverted terminal repeat (ITR) sequences. The DNA genome of parvoviruses encode for proteins required for replication (Rep) and encapsidation (Cap). Adeno-associated virus (AAV) is a defective parovirus that replicates only in cells in which certain functions, called “helper functions” are provided. Usually these functions are provided by helper virus infection. General reviews of parvovirus, including AAV, may be found in, for example, Carter (1989)
Handbook of Parvoviruses
; Berns (1995)
Virology
, Vol. 2, Raven Press, New York pages 2173-2197; Carter et al. (1983) In “The Parvoviruses” (K. I. Berns, ed.) Plenum Press, New York; Berns.
The native AAV genome is a linear single-stranded DNA molecule of approximately 4,675 nucleotides. Srivastava et al. (1983)
J. Virol
. 45:555-564. The native AAV genome contains sequences encoding Rep and Cap proteins (the rep and cap genes, respectively) flanked by an inverted terminal repeat (ITR) sequence of 145 nucleotides. Hermonat et al. (1984)
J. Virol
. 51:329-339; and Tratschin et al. (1984)
J. Virol
. 51:611-619. The life cycle of AAV is presented below. The life cycle of other parvoviruses is similar, with the exception that other parvoviruses do not require helper functions for replication (except to the extent they could require a host cell to go into S phase).
AAV Life Cycle
In outline, a productive AAV infective cycle in a cell which has been infected with a second, helper virus (or in a cell in which helper functions are present) proceeds as follows (see FIG.
1
). Adsorption of AAV to a host cell is followed by inserting the single-stranded viral genome in a process generally known in the art as “transduction”. In the presence of certain host cell functions related to replication (such as DNA polymerases), the incoming single-stranded viral genome is converted to a double-stranded replicative form. See FIG.
2
. Initiation of this single-strand to double-strand (SS→DS) conversion is believed to involve formation of a hairpin structure by sequences within the AAV ITR, which generates a template-primer structure from which initiation of DNA replication can proceed. The product of this SS→DS conversion, the replicative form (RF), is a self-complementary double-stranded molecule that is covalently closed at one end (the end at which replication was initiated). See FIG.
3
. The RF is thus a double-stranded molecule having the same sequence complexity, but approximately twice the molecular weight, of the incoming AAV genome (i.e., for a native genome of approximately 4.7 kilobases, the RF will have a molecular weight corresponding to 4.7 kilobase pairs). Although formation of a terminal hairpin to prime replication is believed to occur rapidly, the extension of this hairpin to form the double-stranded RF is postulated to be one of the rate-limiting steps in AAV replication. This process of RF generation can occur in the absence of helper function but is believed to be enhanced by helper function. See Carter, B. et al. (1990) vol. 1, pp. 169-226 and 255-282. Cells that are capable of producing AAV progeny are generally considered by those skilled in the art as “permissive” cells, and this process of conversion to double-stranded template is also known as “metabolic activation”.
Subsequent to its formation, the RF is replicated to generate progeny RFs, in a process facilitated by AAV rep gene products and certain helper functions (see below). In addition, the RF serves as template for the formation of progeny AAV genomes, which are packaged into virus particles. These genomes are single-stranded DNA molecules of approximately 4.7 kb and represent both polarities as found in the double-stranded RF molecule.
In addition to being necessary for the synthesis of progeny AAV genomes, formation of the RF is required for transcription of viral proteins (or, in the case of recombinant AAV, the transcription of heterologous sequences such as a transgene) to occur, since cellular RNA polymerizing systems require a double-stranded template. Transcription of the AAV rep and cap genes results in production of Rep and Cap proteins. The viral Rep proteins facilitate amplification of the RF, generation of progeny viral genomes and may also play a role in viral transcriptional regulation. The viral Cap proteins are the structural proteins of the viral capsid. Single-stranded progeny viral genomes of both polarities are encapsidated into daughter virus particles, which are then released from the host cell.
Helper functions involved in the replication of the RF, as described above, can be provided by co-infection of AAV-infected cells with adenoviruses, herpesviruses or poxviruses. Carter (1990) supra. Alternatively, cells may contain integrated genes, viral or otherwise, that supply helper function. In addition, the requirement for helper function can sometimes be bypassed by treatment of AAV-infected cells with chemical and/or physical agents, such as hydroxyurea, ultraviolet irradiation, X-irradiation or gamma irradiation, for example, that may induce cellular repair, recombination and/or replication systems, or may otherwise affect cellular DNA metabolism. Yakobson et al. (1987)
J. Virol
. 61:972-987; Yakobson et al. (1988)
J. Virol
. 63:1023-1030; Bantel-Schaal, U. et al. (1988)
Virology
164:64-74; Bantel-Schaal, U. et al. (1988)
Virology
166:113-122; and Yalkinoglu et al. (1988)
Cancer Res
. 48:3123-3125. Although replication of the RF can occur, to some extent, in the absence of helper function; in general, this process is slow and/or inefficient in the absence of helper function.
De la Maza and Carter (1980)
J. Biol. Chem
. 255:3194-3203 describe variant AAV DNA molecules, obtained from AAV particles. Some of these molecules are less than unit length and display properties suggesting that they possess regions of self-complementarity. Hauswirth and Bems (1979)
Virology
93:57-68 describe similar variant molecules obtained from AAV-infected cells. See FIG.
4
. These molecules did not contain heterologous sequences; consequently their ability to express a heterologous sequence could not be evaluated.
Recombinant AAV Vectors and Viruses
The native AAV genome has been used as the basis of vector systems for the delivery and expression of heterologous genes in host cells such as mammalian cells, such as for gene therapy. Muzyczka (1992)
Curr. Top. Microbiol. Immunol
. 158:97-129; Carter, B. J. (1992)
Curr. Op. Biotechnol
. 3:535-539; and Flotte et al. (1995)
Gene Therapy
2:357-362. Recombinant AAV (RAAV) vectors, based on the native AAV genome, are generally produced by deletion of rep and/or cap sequences and replacement by a heterologous sequence. Thus rAAV vectors generally comprise a single-stranded DNA molecule comprising a heterologous gene sequence or sequences flanked by at least one AAV ITR, and typically by two AAV ITRs, one at each end. Additional sequences involved in regulation of expression of the heterologous sequence, such as promoters, splice sites, introns, sequences related to mRNA transport and stability, polyadenylation signals and ribosomal binding sites, can also be included in
Housel James
Morrison & Foerster / LLP
Targeted Genetics Corporation
Winkler Ulrike
LandOfFree
Metabolically activated recombinant viral vectors and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Metabolically activated recombinant viral vectors and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Metabolically activated recombinant viral vectors and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3109975